Iukhimets V A, Pilipchuk V N
Klin Med (Mosk). 1990 Feb;68(2):91-4.
Seventy-two patients with chronic bronchitis were examined and divided into 3 groups. Group I consisted of patients with chronic catarrhal bronchitis (CCB) group II of those with chronic purulent bronchitis (CPB), group III of subjects with bronchitis associated with purulent destructive pulmonary diseases. All the patients received combined treatment with decamethoxin as an antibacterial modality. It was found that decamethoxin promotes elimination of the infection of the bronchial secretion in 60% of chronic bronchitis suffers, the incidence of microorganisms resistent to several antibiotics reduced 2-fold. Local use of decamethoxin as an antibacterial and antiinflammatory drug in multimodality treatment of chronic purulent bronchitis proved highly effective.
对72例慢性支气管炎患者进行了检查，并将其分为3组。第一组由慢性卡他性支气管炎（CCB）患者组成，第二组由慢性化脓性支气管炎（CPB）患者组成，第三组由伴有化脓性破坏性肺部疾病的支气管炎患者组成。所有患者均接受了地塞米松作为抗菌药物的联合治疗。结果发现，地塞米松可使60%的慢性支气管炎患者的支气管分泌物感染得到消除，对多种抗生素耐药的微生物发生率降低了2倍。在慢性化脓性支气管炎的多模式治疗中，局部使用地塞米松作为抗菌和抗炎药物被证明是非常有效的。
